By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its first-quarter revenues increased 10 percent year over year, with particularly strong growth from its SAFC business unit.

The St. Louis-based chemicals and research products firm reported total sales of $623 million, up 10 percent from $569 million for the first quarter of 2010. On an organic basis, the firm's sales were up 7 percent year over year, and it beat analysts' consensus estimate of $602.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.